STRATIVA SPIN OFF/IPO

[Anonymous]

I did and was very disappointed

They would slash the sales force and of course cut salaries and benefits. They owe no allegiance to american workers and would be hungry for profits. You are a fool to believe we would keep what we have. Reps are a dying breed and dime a dozen.

Allegiance? Give me a break. Some here might question that.

 

[Anonymous]

Strativa as a stand alone gains more creditabilty each passing day. With oravig and zuplenz sales starting to take off, value increases dramatically. There is serious pressure to perform with so much on the line!

 

[Anonymous]

Most of these comments reek of RP. Same writing style as emails, same tone. Stop trying to fight the general opinion. The sales force is right on with thoughts on management.

First you say that we are hiring the best reps, then follow it with "reps are a dime a dozen"

You'll get your package regardless and follow PL to the next company. You have zero ability to motivate, inspire or coach. Watching you on stage is painful. You have your group of favs at each level and everyelse is fair game to be ridiculed, abused and finally let go.

You are right that Par hires only the best and opportunities for sales reps are dwindling. Do your best as that is what is expected and you will be successful. It is as simple as that.

 

[Anonymous]

You are right that Par hires only the best and opportunities for sales reps are dwindling. Do your best as that is what is expected and you will be successful. It is as simple as that.

and up early and stay late



r

 

[Anonymous]

and up early and stay late



r

M&A activity picking up. Hmmmmmmmm

 

[Anonymous]

bright future acc to fierce


By Anonymous | Posted 9:14am | August 12, 2010
Par Pharma is an up and comer with strong growth, a low PE and a very strong pipeline including generic zetia

reply
By Anonymous | Posted 12:38pm | August 12, 2010
How is Par an "up and comer"??? They were founded in 1978!

reply
By Anonymous | Posted 3:05pm | August 12, 2010
Par has a very bright future. Par has increasing earnings and cash flow and a very promising pipeline. There are billions in first to file opportunities and 3 new branded compounds hitting the market. Zetia alone does 1.4b in annual sales and par has 180 day exclusivity.

reply
By Anonymous | Posted 9:54pm | August 23, 2010
where is ranbaxy? I think it is bigger than Dr. reddy.

reply
By Anonymous | Posted 8:44am | August 24, 2010
Par Pharma is launching 2 new compounds oravig and zuplenz this week. Par (PRX) has been hitting on all cylinders recently with record earnings.



Read more: Top 10 Generic Drug Companies 2010 - FiercePharma http://www.fiercepharma.com/special...rug-companies-2010#comment-3053#ixzz0xWjVZevA
Subscribe: http://www.fiercepharma.com/signup?sourceform=Viral-Tynt-FiercePharma-FiercePharma

 

[Anonymous]

Launch has exceeded expectations and off to a very strong start!

 

[Anonymous]

Launch has exceeded expectations and off to a very strong start!

I will say it again that morale is at an all time high. Sales are strong and we are in the sweet spot!

 

[Anonymous]

I will say it again that morale is at an all time high. Sales are strong and we are in the sweet spot!

we are so lucky to work for par



Good news: Merck to add 310 jobs; bad news: Biovail/Valeant to cut 1,100
September 8, 2010 — 3:06pm ET | By George Miller
Related Stories
Teva workers were WARNed of layoffs last May
Lilly, Pfizer announce manufacturing cuts
Pharma places fifth on never-to-recover job loss list
Novel ops could protect Genzyme workers from layoffs
Merck, Eli Lilly cuts hit those in mid, late career
Tools Subscribe
Email
Print
Comment
Contact Author
Reprint
It promised North Carolina 440 jobs in two years to meet increased demand for its vaccines. Merck now says it will add 310 more. "We have grown much faster than anyone had anticipated," says plant manager John Wagner. Separately, the drug giant says it is delaying the closure of some Dutch operations while it sorts out alternatives for employees. Both the U.S. and Canada will suffer job losses thanks to synergies identified in the Biovail acquisition of Valeant. The combined 4,400-employee workforce is expected to be trimmed by 25 percent



Read more: Good news: Merck to add 310 jobs; bad news: Biovail/Valeant to cut 1,100 - FiercePharma Manufacturing http://www.fiercepharmamanufacturin...il-valeant-cut-1-100/2010-09-08#ixzz0z5ar3xCB
Subscribe: http://www.fiercepharmamanufacturing.com/signup?sourceform=Viral-Tynt-FiercePharma Manufacturing-FiercePharma Manufacturing

 

[Anonymous]

No layoffs here as demand is super strong

 

[Anonymous]

No layoffs here as demand is super strong

No layoffs under current mgt, all bets off upon buyout

 

[Anonymous]

No layoffs under current mgt, all bets off upon buyout

Underperformers will be let go, you can bank on that

 

[Anonymous]

Underperformers will be let go, you can bank on that

as they should

 

[Anonymous]

Will MS be let go? I hope so, our region is sucking wind!!!!

 

[Anonymous]

Will MS be let go? I hope so, our region is sucking wind!!!!

sure you are last but q to q is

 

[Anonymous]

ever so likely buyout will make spin off moot

 

[Anonymous]

ever so likely buyout will make spin off moot

Maybe the buyout is just of Strativa?

 

[Anonymous]

Maybe the buyout is just of Strativa?

possible as strativa nears huge profits with strong sales of oravig and stalwarts nascobal megace zuplenz etc

 

[Anonymous]

possible as strativa nears huge profits with strong sales of oravig and stalwarts nascobal megace zuplenz etc

they are interested in all of par esp generics


pity the reps who will then realize how good the HAD it

 

[Anonymous]

they are interested in all of par esp generics


pity the reps who will then realize how good the HAD it

when will the cat get out of the bag?